Faron Pharmaceuticals Oy (OHEL:FARON) Buildings And Improvements : €0.30 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Faron Pharmaceuticals Oy Buildings And Improvements?

Faron Pharmaceuticals Oy's quarterly buildings and improvements declined from Dec. 2023 (€0.20 Mil) to Jun. 2024 (€0.00 Mil) but then increased from Jun. 2024 (€0.00 Mil) to Dec. 2024 (€0.30 Mil).

Faron Pharmaceuticals Oy's annual buildings and improvements declined from Dec. 2022 (€0.31 Mil) to Dec. 2023 (€0.20 Mil) but then increased from Dec. 2023 (€0.20 Mil) to Dec. 2024 (€0.30 Mil).

Faron Pharmaceuticals Oy Buildings And Improvements Historical Data

The historical data trend for Faron Pharmaceuticals Oy's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faron Pharmaceuticals Oy Buildings And Improvements Chart

Faron Pharmaceuticals Oy Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

0.31

0.20

0.30

Faron Pharmaceuticals Oy Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial															0.31	-	0.20	-	0.30

Faron Pharmaceuticals Oy Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Faron Pharmaceuticals Oy Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Faron Pharmaceuticals Oy (OHEL:FARON) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

FARN:UK 4FR:Germany

Address

Joukahaisenkatu 6 B, Turku, FIN, 20520

Website

https://www.faron.com

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in the regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is an anti-viral and anti-inflammatory agent, being tested for the prevention of complications that arise from cytokine release syndrome, or hyperinflammatory conditions.

Faron Pharmaceuticals Oy Headlines

No Headlines